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Active surveillance culture (ASC) can help detect hidden reservoirs, but the routine use of 
ASC for extended spectrum β-lactamase-producing Enterobacteriaceae is controversial in 
an endemic situation. We aimed to determine the prevalence and risk factors of extended 
spectrum β-lactamase-producing Klebsiella pneumoniae (EBSL-Kpn) colonization among 
intensive care unit (ICU)-admitted patients. Prospective screening of ESBL-Kpn coloniza-
tion was performed for ICU-admitted patients within 48 hours for two months. A perirectal 
swab sample was inoculated on MacConkey agar supplemented with 2 μg/mL ceftazidime. 
ESBL genotype was determined by PCR-sequencing, and clonal relatedness was evalu-
ated by pulsed-field gel electrophoresis (PFGE). The risk factors of ESBL-Kpn colonization 
were evaluated. The ESBL-Kpn colonization rate among the 281 patients at ICU admis-
sion was 6.4% (18/281), and blaCTX-M-15 was detected in all isolates. ESBL producers also 
showed resistance to fluoroquinolone (38.9%, 7/18). All isolates had the same ESBL gen-
otype (blaCTX-M-15) and a highly clustered PFGE pattern, suggesting cross-transmission 
without a documented outbreak. In univariate analysis, the risk factor for ESBL-Kpn colo-
nization over the control was the length of hospital stay (odds ratio=1.062; P =0.019). 
Routine use of ASC could help control endemic ESBL–Kpn for ICU patients.
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Active surveillance culture (ASC) can elucidate hidden reser-
voirs, which may be delayed or entirely missed in culture results 
obtained during routine clinical care [1]. To date, there is no 
consensus regarding the routine use of ASC for extended spec-
trum β-lactamase-producing Enterobacteriaceae (ESBL-E) in a 
non-epidemic situation. In most Korean hospitals, ASC has not 
been routinely recommended because of the low prevalence 
and cost. However, as the epidemiology changes continuously, 
the usefulness of ASC should be evaluated considering local 
epidemiological data and patient vulnerability. 
Klebsiella pneumoniae isolates are a common cause of infec-
tions in intensive care unit (ICU) patients, and colonizers in the 
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gut could be a source of infection [2]. According to a Korean 
Global Antimicrobial Resistance Surveillance System (Kor-GLASS) 
report based on 2017 data, the resistance rate to cefotaxime 
was 27% in K. pneumoniae blood isolates from May 2016 to 
April 2017 in six sentinel hospitals [3]. The antimicrobial resis-
tance rate to cefotaxime in K. pneumoniae isolates from ICU 
patients is higher than that of non-ICU patients [2]. 
Society for Health Care Epidemiology of America recommends 
screening methicillin-resistant Staphylococcus aureus and van-
comycin-resistant enterococci carriers, based on early research 
conducted in the mid-2000s [4]; however, there was not enough 
evidence for the usefulness of screening ESBL-E [5]. To fill this 
gap and add to the existing knowledge, we aimed to evaluate 
the prevalence and risk factors for ESBL-producing K. pneumo-
niae (ESBL-Kpn) colonization in ICU patients. We hope this data 
will provide the background evidence for applying routine active 
surveillance for ESBL-Kpn colonization in high-risk patients as 
an infection-control policy. The study was approved by the Insti-
tutional Review Board of National Health Insurance Service Il-
san Hospital, Goyang, Korea (NHIMC 2018-04-001), which waiv ed 
the need for informed consent.
From May to July 2016, ESBL-Kpn colonization was screened 
prospectively within 48 hours for all 281 patients admitted to a 
surgical or medical ICU at a general hospital in Gyeonggi-do 
province, Korea. ASC was carried out on perirectal swab sam-
ples, which were then inoculated on MacConkey agar supple-
mented with 2 μg/mL ceftazidime. Identification and susceptibil-
ity testing were performed using a MicroScan WalkAway plus 
system (Beckman Coulter Inc., West Sacramento, CA, USA) 
and a MicroScan Neg Breakpoint Combo Type 44 panel (Sie-
mens Healthcare Diagnostics Inc., West Sacramento, CA, USA). 
Antibiotic susceptibility was interpreted using the CLSI guide-
lines [6]. ESBL-genes were identified by PCR and direct sequenc-
ing using gene-specific primers [7]. Cases with a discrepant 
phenotype and genotype, which showed a positive ESBL result 
by MicroScan without detection of ESBL genes, were confirmed 
using a double-disk synergy test [8]. Pulsed-field gel electro-
phoresis (PFGE) was performed, and the patterns were analyzed 
using InfoQuest FP software (Bio-Rad, Hercules, CA, USA) to 
generate a dendrogram based on the unweighted pair-group 
method, with an arithmetic average (UPGMA) based on Dice’s 
coefficient with 1% band-position tolerance and 0.5% optimiza-
tion settings [9].
For risk factor analysis, a case-control study with a 1:4 ratio 
(18 cases and 72 controls) was conducted. The control group 
included randomly selected patients without ESBL-E isolation in 
ASC. Clinical information (age, sex, hospital stay, site of acquisi-
tion, previous antibiotic use within 90 days before ASC, and ICU 
types) was collected by reviewing the medical records. Sites of 
acquisition were identified as described by Friedman, et al. [10] 
with some modifications. Briefly, hospital-acquired infection/col-
onization was defined by a positive culture obtained from pati-
ents who had been hospitalized for 48 hours or longer. Commu-
nity-onset infection/colonization was defined by a positive culture 
obtained at the time of hospital admission or within 48 hours 
post admission. Community-onset consisted of two groups: com-
munity-onset healthcare-associated and community-associated. 
Community-onset healthcare-associated cases had any of the 
following histories: attended a hospital or hemodialysis clinic or 
received intravenous chemotherapy in the last 30 days; hospi-
talized in an acute-care hospital for two or more days in the last 
90 days, or were transferred-in from another healthcare facility 
before K. pneumoniae isolation. The remaining cases were de-
fined as community-associated.
The age and hospital days were summarized as median, and 
other variables as N (%) of patients. Continuous variables, such 
as age, were analyzed using the Mann-Whitney U test. Categori-
cal variables were compared using the chi-squared test to iden-
tify independent risk factors. Odds ratio (OR) and 95% confi-
dence interval (CI) were calculated for binomial variables. Vari-
ables with P <0.1 in univariate analyses were included, if multi-
variate logistic regression analysis was needed to identify inde-
pendent risk factors for ESBL-Kpn colonization. Statistical signif-
icance was defined as P <0.05. Data were analyzed using SPSS 
version 23 (IBM Corp., Armonk, NY, USA). 
The ESBL-Kpn colonization rate among the 281 patients at 
ICU admission was 6.4% (18/281), and blaCTX-M-15 was detected 
in all isolates. ESBL producers also showed resistance to fluoro-
quinolone (38.9%, 7/18). The PFGE profiles showed one clus-
tered group and other heterogeneous patterns with 80% simi-
larity (Fig. 1).
In univariate analysis, the only significant risk factor for ESBL-
Kpn colonization over the control was hospital stay (OR=1.062; 
P =0.019). Other factors, such as site of acquisition, previous 
antibiotic use, and ICU type were not statistically significant (Ta-
ble 1). 
Gastrointestinal colonization by K. pneumoniae has been con-
firmed as a significant risk factor for infection in ICUs; a half of 
K. pneumoniae infections originate from patient microbiota [11]. 
Disruption of normal barriers, for example by gastric acidity and 
colon microflora, facilitates the overgrowth of pathogens; many 
mechanisms, including bacterial translocation from the gut and 
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Fig. 1. Dendrogram of XbaI-restricted DNA of colonizing ESBL-producing Klebsiella pneumoniae isolated from ICU-admitted patients 
(N=14). Four ESBL-producing K. pneumoniae isolates were excluded because of repeated failure of reculture. Pulsed-field gel electropho-
resis was performed with size marker, Lambda Ladders (Promega, Fitchburg, WI, USA). 
Abbreviations: ESBL, extended-spectrum beta-lactamase; ICU, intensive care unit.
Table 1. Risk factors of ESBL-producing Klebsiella pneumoniae colonization: univariate analysis 
Clinical features*
ASC for ESBL-producing K. pneumoniae
OR (95% CI) P
Positive (N=18) Negative (N=72)
Age (yr)
   Median (IQR) 70.5 (58.0–80.5) 73.5 (60.3–79.8) 1.008 (0.971–1.047) 0.675
Male 12 (66.7) 35 (48.6) 2.114 (0.716–6.248) 0.176
Female 6 (33.3) 37 (51.4) - -
Hospital stay (days) 
   Median (IQR) 3 (1–14) 2 (1–5) 1.062 (1.010–1.117) 0.019
Site of acquisition
Community-associated 1 (5.6) 13 (18.1) 0.267 (0.033–2.189) 0.219
Community-onset healthcare-associated 8 (44.4) 24 (33.3) 1.600 (0.559–4.576) 0.381
Hospital-acquired 9 (50.0) 35 (48.6) 1.057 (0.376–2.970) 0.916
Previous antibiotics use
   3rd cephalosporin 2 (11.1) 6 (8.3) 1.375 (0.253–7.459) 0.712
   Fluoroquinolone 1 (5.6) 10 (13.9) 0.365 (0.044–3.052) 0.352
   Any antibiotics 13 (72.2) 38 (52.8) 2.326 (0.751–7.205) 0.143
ICU type
   Medical 8 (44.4) 32 (44.4) 1.000 (0.354–2.828) 1.000
   Surgical 10 (55.6) 40 (55.6) - -
*Data summarized as N (%) of patients unless otherwise indicated.
Bold formatting indicates statistical significance.
Abbreviations: ASC, active surveillance culture; ESBL, extended-spectrum-β-lactamase; OR, odds ratio; CI, confidence interval; IQR, interquartile range; ICU, 
intensive care unit. 
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exogenous translocation via contaminated skin, can contribute 
to these infections [12]. Furthermore, patient with gastrointesti-
nal problems, such as fecal incontinence and diarrhea, could 
result in the spread of pathogens into the health-care environ-
ment, and treatment with antibiotics places a higher selective 
pressure on colonization by the pathogen [12].
Infections by a multi-drug resistant pathogen, such as ESBL-
Kpn, which usually carries resistance to other classes of antibi-
otics, could fail to respond to treatment, increasing medical costs, 
prolonging hospital stays, and elevating the socioeconomic bur-
den [13]. K. pneumoniae is one of the most important hospital 
pathogens, with a high mortality rate, particularly due to multi-
drug-resistant ESBL-producing strains [14]. Moreover, K. pneu-
moniae is known to be 3.7-fold more transmissible than Esche-
richia coli in mathematical modeling analysis, although the un-
derlying factors of this higher transmissibility have not been elu-
cidated [15]. In our study, the prevalence of ESBL-Kpn coloni-
zation was 6.4% at ICU admission. In previous studies, ESBL-
Kpn carriage rates ranged from 45% (18/40) to 6.9% (24/347) 
in ICU patients [16, 17]. 
The ESBL-Kpn isolates in our study had the same genotype 
(blaCTX-M-15), and nine of the 14 isolates showed identical PFGE 
patterns, suggesting cross-transmission without a documented 
outbreak. A limitation of this study was that we used ceftazidime 
in ASC, which could result in the low detection of CTX-M-14 
type because the hydrolysis of ceftazidime is lower than that of 
cefotaxime with this CTX-M type. We could not detect carbape-
nem-resistant K. pneumoniae; although the prevalence of car-
bapenem-resistant Enterobacteriaceae (CRE) is still low in Korea 
[18], the recent sharp rise in CRE caused by carbapenemase-
producing Enterobacteriaceae (CPE) has created challenges for 
infection control in Korea [19]. K. pneumoniae is the most com-
mon bacterial type of CPE, carrying various types of carbapene-
mases, such as K. pneumoniae carbapenemase, New Delhi metallo-
β-lactamase, and OXA-type carbapenemases [20]. Given that 
CPE may emerge in Korea, the routine application of ASC not 
only for ESBL-Kpn but also for CPE for ICU patients should be 
considered in the near future. 
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